Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;81(6):542-50.
doi: 10.1007/s00104-010-1888-4.

[Interventional procedures for hepatic metastases]

[Article in German]
Affiliations
Review

[Interventional procedures for hepatic metastases]

[Article in German]
T Helmberger. Chirurg. 2010 Jun.

Abstract

The therapeutic concept for hepatic metastases is mainly based on surgical resection and systemic chemotherapy. Considering technical respectability, oncological significance and limiting comorbidities, only 10-30% of patients with hepatic metastases can undergo surgery with a curative intention. Patients assessed as being non-resectable qualify in general for (palliative) chemotherapy. However, for many patients surgical therapy of the liver is no longer possible due to medical or technical reasons, nevertheless, the total tumor load is still limited, which makes an interventional, local ablative therapy approach promising, with and without chemotherapy. Thus, various interventional-radiological, minimally invasive techniques could be successfully established as oncological therapy components besides surgery and chemotherapy. These types of intervention encompass mainly chemotherapy (percutaneous alcohol instillation, transarterial chemoembolization and transarterial chemotherapy), thermotherapy (radiofrequency, laser and microwave ablations) and radio-ablative procedures (radio-embolization, selective internal radiation therapy SIRT, interstitial and catheter-guided brachytherapy). Incorporating these procedures into therapeutic multimodal concepts inaugurates a significantly broadened therapy spectrum with a clear additional improvement in patient prognosis.

PubMed Disclaimer

References

    1. Ann Oncol. 2001 Dec;12(12):1711-20 - PubMed
    1. J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S342-7 - PubMed
    1. Anticancer Res. 2006 Jan-Feb;26(1B):671-80 - PubMed
    1. Acta Radiol. 2007 Apr;48(3):253-8 - PubMed
    1. Cancer J. 2006 Jul-Aug;12(4):318-26 - PubMed

MeSH terms

Substances

LinkOut - more resources